The Recall Desk
SevereFDA (Drugs)·D-0479-2025·Announced 2025-07-02

Semaglutide 2.5 mg/mL pre-filled syringe recall for sterility assurance

Thrive Health Solutions is recalling Semaglutide 2.5 mg/mL pre-filled syringes (Lot #H270221) because the manufacturer cannot assure sterility of the product.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: This is an FDA Class II recall of a sterile drug product where sterility cannot be assured. Lack of sterility in injectable medications poses risk of serious infection and potential hospitalization, meeting the Severe criteria.

Plain-English summary

Thrive Health and Wellness, LLC, dba Thrive Health Solutions, is recalling Semaglutide 2.5 mg/mL pre-filled syringes distributed nationwide. The affected lot is H270221 with an expiration date of 12/26/2025. The recall was initiated because the manufacturer lacks assurance of sterility for the product.

Patients currently using this medication should contact their healthcare provider for guidance. Do not use syringes from Lot #H270221. Contact Thrive Health Solutions or your healthcare provider with questions or to report any adverse effects.

The recalled product

Product
Semaglutide, 2.5 mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112
Manufacturer
Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado)
Hazard
  • lack-of-sterility
  • infection-risk

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot #: H270221
  • Exp 12/26/2025

Distribution

Distributed nationwide across the United States.